Maternal circulating leptin, tumor necrosis factor-alpha, and interleukine-6 in association with gestational diabetes mellitus: a systematic review and meta-analysis

References

• McIntyre HD, Catalano P, Zhang C, et al. Gestational diabetes mellitus. Nat Rev Dis Primers. 2019;5(1):1–13.
   PubMedGoogle Scholar
• Miehle K, Stepan H, Fasshauer M. Leptin, adiponectin and other adipokines in gestational diabetes mellitus and pre-eclampsia. Clin Endocrinol. 2012;76(1):2–11.
   PubMed Web of Science ®Google Scholar
• Al-Badri MR, Zantout MS, Azar ST. The role of adipokines in gestational diabetes mellitus. Ther Adv Endocrinol. 2015;6(3):103–108.
   PubMed Web of Science ®Google Scholar
• Abell SK, Courten BD, Boyle JA, et al. Inflammatory and other biomarkers: role in pathophysiology and prediction of gestational diabetes mellitus. IJMS. 2015;16(12):13442–13473.
   Google Scholar
• Bawah AT, Seini MM, Abaka-Yawason A, et al. Leptin, resistin and visfatin as useful predictors of gestational diabetes mellitus. Lipids Health Dis. 2019;18(1):221.
   PubMed Web of Science ®Google Scholar
• Mosavat M, Omar SZ, Tan PC, et al. Leptin and soluble leptin receptor in association with gestational diabetes: a prospective case–control study. Arch Gynecol Obstet. 2018;297(3):797–803.
   PubMed Web of Science ®Google Scholar
• Yaqiong L, Guohua W, Fuyan Y, et al. Study on the levels of 25(OH)D, inflammation markers and glucose and fat metabolism indexes in pregnant women of han nationality in Jiangsu province with gestational diabetes mellitus. Medicine. 2020;99(35):e21654.
   PubMed Web of Science ®Google Scholar
• Yu H, Liu Z, Dong S. Changes in intestinal flora, TNF-α, L-17, and IL-6 levels in patients with gestational diabetes mellitus. Eur J Inflamm. 2018;16:205873921879355.
   Web of Science ®Google Scholar
• Zhang J, Chi H, Xiao H, et al. Interleukin 6 (IL-6) and tumor necrosis factor α (TNF-α) single nucleotide polymorphisms (SNPs). Inflammation and Metabolism in Gestational Diabetes Mellitus in Inner Mongolia. Med Sci Monit. 2017;23:4149–4157.
   PubMed Web of Science ®Google Scholar
• Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol. 2009;62(10):e1–e34.
   PubMed Web of Science ®Google Scholar
• Wells GA, Shea B, O’connell D, et al. The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomized studies in meta-analysis. Ottawa, Ontario: The Ottawa Health Research Institute.
   Google Scholar
• Shih T, Lee K, Grogan T, et al. Infliximab in hidradenitis suppurativa: a systematic review and meta-analysis. Dermatol Ther. 2022;35(9):e15691.
   PubMed Web of Science ®Google Scholar
• Guyatt G, Oxman AD, Akl EA, et al. GRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011;64(4):383–394.
   PubMed Web of Science ®Google Scholar
• Higgins J. Cochrane handbook for systematic reviews of interventions. Version 5.1. 0. The Cochrane Collaboration [updated 2011 Mar]. Available from: cochrane-handbook.org. 2011.
   Google Scholar
• Qiu C, Williams MA, Vadachkoria S, et al. Increased maternal plasma leptin in early pregnancy and risk of gestational diabetes mellitus. Obstet Gynecol. 2004;103(3):519–525.
   PubMed Web of Science ®Google Scholar
• López-Tinoco C, Roca M, Fernández-Deudero A, et al. Cytokine profile, metabolic syndrome and cardiovascular disease risk in women with late-onset gestational diabetes mellitus. Cytokine. 2012;58(1):14–19.
   PubMed Web of Science ®Google Scholar
• Sommer C, Jenum AK, Waage CW, et al. Ethnic differences in BMI, subcutaneous fat, and serum leptin levels during and after pregnancy and risk of gestational diabetes. Eur J Endocrinol. 2015;172(6):649–656.
   PubMed Web of Science ®Google Scholar
• Bossick AS, Peters RM, Burmeister C, et al. Antenatal inflammation and gestational diabetes mellitus risk among pregnant African-American women. J Reprod Immunol. 2016;115:1–5.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Hao-hang Z, Jia-hui L, et al. Changes in serum adipocyte fatty acid-binding protein in women with gestational diabetes mellitus and normal pregnant women during mid- and late pregnancy. J Diabetes Investig. 2016;7(5):797–804.
   PubMed Web of Science ®Google Scholar
• Abell SK, Shorakae S, Harrison CL, et al. The association between dysregulated adipocytokines in early pregnancy and development of gestational diabetes. Diabetes Metab Res Rev. 2017;33(8):e2926.
   Web of Science ®Google Scholar
• Fatima SS, Alam F, Chaudhry B, et al. Elevated levels of chemerin, leptin, and interleukin-18 in gestational diabetes mellitus. J Matern Fetal Neonatal Med. 2017;30(9):1023–1028.
   PubMed Web of Science ®Google Scholar
• Näslund Thagaard I, Krebs L, Jens-Christian H, et al. Adiponectin and leptin as first trimester markers for gestational diabetes mellitus: a cohort study. Clin Chem Lab Med. 2017;55(11):1805–1812.
   PubMed Web of Science ®Google Scholar
• Zhao XL, Liu JL, Shen LL, et al. Correlation between inflammatory markers (hs-CRP, TNF-alpha, IL-1 beta, IL-6, IL-18), glucose intolerance, and gestational diabetes mellitus in pregnant women. Int J Clin Exp Med. 2018;11(8):8310–8316.
   Web of Science ®Google Scholar
• Francis EC, Li MY, Hinkle SN, et al. Adipokines in early and mid-pregnancy and subsequent risk of gestational diabetes: a longitudinal study in a multiracial cohort. BMJ Open Diabetes Res Care. 2020;8(1):e001333.
   PubMed Web of Science ®Google Scholar
• Schuitemaker JHN, Beernink RHJ, Franx A, et al. First trimester secreted Frizzled-Related protein 4 and other adipokine serum concentrations in women developing gestational diabetes mellitus. PLoS One. 2020;15(11):e0242423.
   PubMed Web of Science ®Google Scholar
• Al-Musharaf S, Sabico S, Hussain SD, et al. Inflammatory and adipokine status from early to midpregnancy in Arab women and its associations with gestational diabetes mellitus. Dis Markers. 2021;2021:1–8.
   Web of Science ®Google Scholar
• Florian AR, Cruciat G, Pop RM, et al. Predictive role of altered leptin, adiponectin and 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid secretion in gestational diabetes mellitus. Exp Ther Med. 2021;21(5):520.
   PubMed Web of Science ®Google Scholar
• Mosavat M, Mirsanjari M, Lwaleed BA, et al. Adipocyte-specific fatty acid-binding protein (AFABP) and chemerin in association with gestational diabetes: a case-control study. J Diabetes Res. 2021;2021:1–7.
   Web of Science ®Google Scholar
• Ye W, Chen L, Yang Y, et al. Formyl peptide receptor-2 is upregulated in the blood and placenta of patients with gestational diabetes mellitus. J Obstet Gynaecol. 2021;47(10):3471–3479.
   Google Scholar
• Hezareh F, Moghaddam-Banaem L, Shahali S. The relationship between maternal serum interleukin-6 and CRP levels at first trimester of pregnancy and gestational diabetes occurrence. Iran J Obstet Gynecol Infertil. 2021;24(5):59–68.
   Google Scholar
• Ye Y, Wu P, Wang Y, et al. Adiponectin, leptin, and leptin/adiponectin ratio with risk of gestational diabetes mellitus: a prospective nested case-control study among Chinese women. Diabetes Res Clin Pract. 2022;191:110039.
   PubMed Web of Science ®Google Scholar
• Xiang L-L, Chen C, Wang Q-Y, et al. Impact of inflammatory factors, hemoglobin A1c, and platelet parameters in gestational diabetes mellitus. Arch Gynecol Obstet. 2023;307:439–446.
   PubMed Web of Science ®Google Scholar
• Sridhar VS, Liu H, Lovblom LE, et al. Associations among biomarkers of inflammation, tubular injury and lipid metabolism with gestational diabetes mellitus status, microalbuminuria and retinopathy in the microalbuminuria and retinopathy in gestational diabetes study. Can J Diabetes. 2023;47:43–50.
   PubMed Web of Science ®Google Scholar
• Diabetes Canada Clinical Practice Guidelines Expert Committee. Diabetes Canada 2018 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada. Can J Diabetes. 2018;42:S1–S325.
   Google Scholar
• Egger M, Smith GD, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–634.
   PubMed Web of Science ®Google Scholar
• Sutton AJ, Duval SJ, Tweedie R, et al. Empirical assessment of effect of publication bias on meta-analyses. BMJ. 2000;320(7249):1574–1577.
   PubMed Web of Science ®Google Scholar
• Ebert T, Gebhardt C, Scholz M, et al. Adipocytokines are not associated with gestational diabetes mellitus but with pregnancy status. Cytokine. 2020;131:155088.
   PubMed Web of Science ®Google Scholar
• Guelfi KJ, Ong MJ, Li S, et al. Maternal circulating adipokine profile and insulin resistance in women at high risk of developing gestational diabetes mellitus. Metabolism. 2017;75:54–60.
   PubMed Web of Science ®Google Scholar
• Xu J, Yan Hong Z, Chen YP, et al. Maternal circulating concentrations of tumor necrosis factor-alpha, leptin, and adiponectin in gestational diabetes mellitus: a systematic review and meta-analysis. Sci World J. 2014;2014:1–12.
   Google Scholar
• McLachlan KA, O’Neal D, Jenkins A, et al. Do adiponectin, TNFalpha, leptin and CRP relate to insulin resistance in pregnancy? Studies in women with and without gestational diabetes, during and after pregnancy. Diabetes Metab Res Rev. 2006;22(2):131–138.
   PubMed Web of Science ®Google Scholar
• MdM R-R, Ramos-García P, López-Tinoco C, et al. Significance of serum-plasma leptin profile during pregnancy in gestational diabetes mellitus: a systematic review and meta-analysis. J Clin Med. 2022;11(9):2433.
   PubMed Web of Science ®Google Scholar
• Khosrowbeygi A, Rezvanfar MR, Ahmadvand H. Tumor necrosis factor- α, adiponectin and their ratio in gestational diabetes mellitus. Caspian J Intern Med. 2018;9(1):71–79.
   PubMed Web of Science ®Google Scholar
• Brink HS, van der Lely AJ, van der Linden J. The potential role of biomarkers in predicting gestational diabetes. Endocr Connect. 2016;5(5):26–34.
   PubMed Web of Science ®Google Scholar